Clinical Trial Update: Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating fucoidan, a seaweed-derived supplement, in cancer survivors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fucoidan (fucoidan)

Snippet

Sponsor: University of Rochester | Conditions: Fatigue, Inflammation | Phase 2 | Status: RECRUITING